This entry covers evaluation under DC 7525. A clinician establishes the diagnosis separately.
How is it connected to service?
The applicable direct, secondary, aggravation or presumptive route determines the service-connection evidence. Use the evidence guide to distinguish these routes.
Explore service-connection evidence →What do the rating levels describe?
A diagnosis does not automatically establish a percentage. These are the source requirements for evaluating severity; related notes and exceptions still apply.
Find DC 7525 in the rating schedule
The highlighted row marks this code. Nearby rows provide context and can describe other conditions. Use the full schedule for applicable headings, footnotes and exceptions.
| Rating | |
|---|---|
| One | ¹ 0 |
| Note: In cases of the removal of one testis as the result of a service-incurred injury or disease, other than an undescended or congenitally undeveloped testis, with the absence or nonfunctioning of the other testis unrelated to service, an evaluation of 30 percent will be assigned for the service-connected testicular loss. Testis, undescended, or congenitally undeveloped is not a ratable disability. | |
| 7525 Prostatitis, urethritis, epididymitis, orchitis (unilateral or bilateral), chronic only: | |
| Rate as urinary tract infection. | |
| For tubercular infections: Rate in accordance with §§ 4.88b or 4.89, whichever is appropriate. | |
| 7527 Prostate gland injuries, infections, hypertrophy, postoperative residuals, bladder outlet obstruction: | |
| Rate as voiding dysfunction or urinary tract infection, whichever is predominant. | |
| 7528 Malignant neoplasms of the genitourinary system | 100 |
| Note—Following the cessation of surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure, the rating of 100 percent shall continue with a mandatory VA examination at the expiration of six months. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no local reoccurrence or metastasis, rate on residuals as voiding dysfunction or renal dysfunction, whichever is predominant. |
Find the dysfunction table named by this code
Read the instruction for this diagnosis first. Then use the matching table for the type of dysfunction it names. Laboratory measurements, leakage, urinary frequency and obstructed voiding answer different rating questions.
Read 38 CFR §4.115a ↗Related notes and evaluation rules
Rate as urinary tract infection. |
For tubercular infections: Rate in accordance with §§ 4.88b or 4.89, whichever is appropriate. |
Which evidence addresses the questions?
- Diagnosis and history: Records identifying the current diagnosis, onset, course, and relevant medical history.
- Diagnostic tests and measurements: Condition-relevant tests, imaging, laboratory results, and objective measurements.
- Symptoms and episodes: Records or statements documenting symptoms, severity, frequency, duration, and episodes.
- Clinical findings: Examination findings that are relevant to the public DBQ or rating criteria.
- Scars and residual findings: Records describing relevant scars and residual physical findings.
- Functional impact: Medical and lay evidence describing work and daily-activity effects.
- Service connection evidence: Evidence addressing an in-service event, exposure, disease, injury, continuity, or a secondary relationship.
Find evidence in the Male Reproductive Organ Conditions (Including Prostate Cancer) questionnaire
Use these section names and page numbers to locate the examiner’s findings. Some sections apply only to particular diagnoses within this family.
- diagnosis · p. 1, 2
- medical history · p. 2, 3
- voiding dysfunction · p. 3, 4
- erectile dysfunction · p. 4
- retrograde ejaculation · p. 4
- male reproductive organ infections, including urinary tract infections · p. 5
- physical exam · p. 5, 6, 7
- tumors and neoplasms · p. 7, 8
- other pertinent physical findings, complications, conditions, signs, symptoms, and scars · p. 8
- diagnostic testing · p. 9
- functional impact · p. 9
- remarks · p. 9
Shared library and examination references
How an independent medical review works →Sources and scope
Clinical and evidence sources
Guide source check: 2026-11-06. Rating-library snapshot: June 30, 2026. Source coverage is distinct from clinical review. This page does not diagnose, adjudicate a claim, or collect medical records.
Shared reference edition 1.2.4 · source check 2026-11-06. Coverage is stated for each framework and is distinct from clinical review. Rating-source snapshot: 2026-06-30.